Literature DB >> 18817874

MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage.

Hideo Kobayashi1, Sharmila Chattopadhyay, Kinshi Kato, Jennifer Dolkas, Shin-Ichi Kikuchi, Robert R Myers, Veronica I Shubayev.   

Abstract

Matrix metalloproteinases (MMPs) emerge as modulators of neuropathic pain. Because myelin protects Abeta afferents from ectopic hyperexcitability and nociception from innocuous mechanical stimuli (or mechanical allodynia), we analyzed the role of MMPs in the development of mechanical allodynia through myelin protein degradation after rat and MMP-9-/- mouse L5 spinal nerve crush (L5 SNC). MMPs were shown to promote selective degradation of myelin basic protein (MBP), with MMP-9 regulating initial Schwann cell-mediated MBP processing after L5 SNC. Acute and long-term therapy with GM6001 (broad-spectrum MMP inhibitor) protected from injury-induced MBP degradation, caspase-mediated apoptosis, macrophage infiltration in the spinal nerve and inhibited astrocyte activation in the spinal cord. The effect of GM6001 therapy on attenuation of mechanical allodynia was robust, immediate and sustained through the course of L5 SNC. In conclusion, MMPs mediate the initiation and maintenance of mechanical nociception through Schwann cell-mediated MBP processing and support of neuroinflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817874      PMCID: PMC2865888          DOI: 10.1016/j.mcn.2008.08.008

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  71 in total

1.  Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia.

Authors:  Yoon Seong Kim; Sung Soo Kim; Jeong Je Cho; Dong Hee Choi; Onyou Hwang; Dong Hoon Shin; Hong Sung Chun; M Flint Beal; Tong H Joh
Journal:  J Neurosci       Date:  2005-04-06       Impact factor: 6.167

2.  Matrix metalloproteinase expression during experimental autoimmune neuritis.

Authors:  P M Hughes; G M Wells; J M Clements; A J Gearing; E J Redford; M Davies; K J Smith; R A Hughes; M C Brown; K M Miller
Journal:  Brain       Date:  1998-03       Impact factor: 13.501

3.  Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres.

Authors:  L S Sorkin; W H Xiao; R Wagner; R R Myers
Journal:  Neuroscience       Date:  1997-11       Impact factor: 3.590

Review 4.  The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system.

Authors:  H P Hartung; B C Kieseier
Journal:  J Neuroimmunol       Date:  2000-07-24       Impact factor: 3.478

5.  Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation.

Authors:  Annemarie Ledeboer; Evan M Sloane; Erin D Milligan; Matthew G Frank; John H Mahony; Steven F Maier; Linda R Watkins
Journal:  Pain       Date:  2005-05       Impact factor: 6.961

6.  Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage.

Authors:  Jian Wang; Stella E Tsirka
Journal:  Brain       Date:  2005-03-30       Impact factor: 13.501

7.  A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy.

Authors:  C Sommer; C Schmidt; A George; K V Toyka
Journal:  Neurosci Lett       Date:  1997-11-14       Impact factor: 3.046

8.  MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve.

Authors:  T A Ferguson; D Muir
Journal:  Mol Cell Neurosci       Date:  2000-08       Impact factor: 4.314

9.  A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-alpha processing attenuates experimental autoimmune neuritis.

Authors:  E J Redford; K J Smith; N A Gregson; M Davies; P Hughes; A J Gearing; K Miller; R A Hughes
Journal:  Brain       Date:  1997-10       Impact factor: 13.501

10.  Matrix metalloproteinases MMP-2 and MMP-9 in denervated muscle and injured nerve.

Authors:  S Kherif; M Dehaupas; C Lafuma; M Fardeau; H S Alameddine
Journal:  Neuropathol Appl Neurobiol       Date:  1998-08       Impact factor: 8.090

View more
  46 in total

1.  Characterization of frequency-dependent responses of the vascular system to repetitive vibration.

Authors:  Kristine Krajnak; G Roger Miller; Stacey Waugh; Claud Johnson; Michael L Kashon
Journal:  J Occup Environ Med       Date:  2012-08       Impact factor: 2.162

Review 2.  Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.

Authors:  Xiao-Min Wang; Tanya J Lehky; Joanna M Brell; Susan G Dorsey
Journal:  Cytokine       Date:  2012-04-24       Impact factor: 3.861

3.  Matrix metalloproteinase inhibition enhances the rate of nerve regeneration in vivo by promoting dedifferentiation and mitosis of supporting schwann cells.

Authors:  Huaqing Liu; Youngsoon Kim; Sharmila Chattopadhyay; Igor Shubayev; Jennifer Dolkas; Veronica I Shubayev
Journal:  J Neuropathol Exp Neurol       Date:  2010-04       Impact factor: 3.685

Review 4.  Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches.

Authors:  Dominic Schomberg; Gurwattan Miranpuri; Tyler Duellman; Andrew Crowell; Raghu Vemuganti; Daniel Resnick
Journal:  Metab Brain Dis       Date:  2015-01-15       Impact factor: 3.584

5.  A sensitive and selective ELISA methodology quantifies a demyelination marker in experimental and clinical samples.

Authors:  Albert G Remacle; Jennifer Dolkas; Mila Angert; Swathi K Hullugundi; Andrei V Chernov; R Carter W Jones; Veronica I Shubayev; Alex Y Strongin
Journal:  J Immunol Methods       Date:  2018-02-08       Impact factor: 2.303

6.  Matrix metalloproteinase-14 both sheds cell surface neuronal glial antigen 2 (NG2) proteoglycan on macrophages and governs the response to peripheral nerve injury.

Authors:  Tasuku Nishihara; Albert G Remacle; Mila Angert; Igor Shubayev; Sergey A Shiryaev; Huaqing Liu; Jennifer Dolkas; Andrei V Chernov; Alex Y Strongin; Veronica I Shubayev
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

7.  Amino acid sequence conservation of the algesic fragment of myelin basic protein is required for its interaction with CDK5 and function in pain.

Authors:  Andrei V Chernov; Albert G Remacle; Swathi K Hullugundi; Piotr Cieplak; Mila Angert; Jennifer Dolkas; Veronica I Shubayev; Alex Y Strongin
Journal:  FEBS J       Date:  2018-08-27       Impact factor: 5.542

8.  Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia.

Authors:  Espen J Walker; Gary A Rosenberg
Journal:  J Neurosci Res       Date:  2010-03       Impact factor: 4.164

9.  Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine.

Authors:  Jun Nagai; Hitoshi Uchida; Yosuke Matsushita; Ryo Yano; Mutsumi Ueda; Masami Niwa; Junken Aoki; Jerold Chun; Hiroshi Ueda
Journal:  Mol Pain       Date:  2010-11-09       Impact factor: 3.395

10.  Spinal activity of interleukin 6 mediates myelin basic protein-induced allodynia.

Authors:  Justin S Ko; Kelly A Eddinger; Mila Angert; Andrei V Chernov; Jennifer Dolkas; Alex Y Strongin; Tony L Yaksh; Veronica I Shubayev
Journal:  Brain Behav Immun       Date:  2016-03-09       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.